Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    dermatology

    Basal cell carcinoma

    Also known as: BCC, Basal cell skin cancer, Basal cell epithelioma, Rodent ulcer

    Basal cell carcinoma (BCC) is a prevalent cutaneous malignancy associated with cumulative ultraviolet radiation exposure. Suspected lesions necessitate formal medical diagnosis, typically via biopsy, and definitive management overseen by a treating skin-cancer clinician. Within a TCM framework, clinical focus is limited to supportive care for comorbid psychological distress, sleep disturbances, or systemic presentations; it cannot determine histological subtype, surgical clearance, or recurrence risk. The cited evidence does not evaluate the efficacy of acupuncture or Chinese herbal medicine for BCC. Photodynamic therapy bibliometric analyses delineate research trends rather than establishing clinical efficacy, genetic studies do not demonstrate therapeutic benefits, and the endometriosis review is not transferable evidence. Safety protocols listed are clinical safeguarding measures rather than findings derived from the cited literature.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Utilise shade, wear photoprotective clothing and broad-brimmed hats, apply broad-spectrum sunscreen, and avoid ultraviolet tanning beds.
    • •Adhere to all scheduled skin-cancer treatment and dermatological surveillance appointments; report any new or evolving lesions to a medical practitioner promptly.
    • •Follow all post-procedural wound-care protocols as directed by the medical team; avoid mechanical irritation of lesions and refrain from applying unprescribed topical products.
    • •Optimise recovery through consistent nutritional intake, adequate sleep hygiene, and gentle physical activity appropriate to the current phase of medical treatment.

    Cautions & Contraindications

    See sources
    • •Do not needle, apply moxa, cup, scrape or massage directly over suspected or confirmed tumours, biopsy sites, open wounds, infected skin or healing treatment fields. This is a precaution; source 2 does not study acupuncture safety.[]
    • •Do not substitute acupuncture, herbs, home light devices or heating for definitive BCC care. Source 2 maps medical PDT research; source 1 concerns endometriosis and cannot justify BCC treatment.[,]
    • •Do not select immune-active herbs or claim cancer prevention from immune-cell associations or shared genetic pathways. Transplant recipients and patients receiving oncology medicines require specialist and pharmacist review before any herbal formula.[,]
    • •Defer elective needling with clinically significant bleeding risk, severe immunosuppression, active infection or unstable illness pending medical clearance. Review pregnancy and perioperative herbal risks individually. These safeguards are not evaluated in the supplied BCC research.[]

    When to reassess or seek care again

    See sources

    Record baseline sleep disturbance, distress, fatigue and dryness on 0–10 scales where relevant. Review supportive care after 2–4 weeks or 2–4 sessions; stop or revise it if there is no meaningful symptom improvement or adverse effects occur. Diagnostic assessment and definitive cancer care must proceed without waiting for this review. New lesion changes, pain, numbness, infection or bleeding trigger medical reassessment. Tumour clearance and recurrence assessment remain the treating specialist's responsibility.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. Journal of clinical medicine · 2026
    2. Photodiagnosis and photodynamic therapy · 2026
    3. Medicine · 2025
    4. Briefings in bioinformatics · 2026

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.